Evidence map›Paper›PMID 33834001›Full record

ArticleFrontiers in oncology2021

Corrigendum: NUSAP1 Promotes Gastric Cancer Tumorigenesis and Progression by Stabilizing the YAP1 Protein.

Hui Guo, Jianping Zou, Ling Zhou, Min Zhong, Yan He, Shanshan Huang, Jun Chen, Junhe Li, Jianping Xiong, Ziling Fang and 1 more

Abstract readPublished Erratum
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. The role and therapeutic value of NUSAP1 in human cancers.Journal of translational medicine · 2025
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Hui GuoDepartment of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Jianping ZouDepartment of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Ling ZhouDepartment of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Min ZhongDepartment of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Yan HeDepartment of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Shanshan HuangDepartment of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Jun ChenDepartment of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Junhe LiDepartment of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Jianping XiongDepartment of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Ziling FangDepartment of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Xiaojun XiangDepartment of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fonc.2020.591698.].

Indexed as

gastric cancerNUSAP1protein stabilitytumorigenesis and progressionYAP1

Identifiers

PMID33834001
PMCPMC8023389

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.